PTC Therapeutics, Inc.PTCTNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Recovery in Progress
Trending higher, below historical average, modest growth trend.
Left:
||||
Year-over-year gross profit growth rate
Latest
-43.23%
↓ 101% below average
Average (39q)
3337.77%
Historical baseline
Range
High:132640.00%
Low:-85.60%
CAGR
+4.8%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -43.23% |
| Q2 2025 | -85.60% |
| Q1 2025 | 490.81% |
| Q4 2024 | 5.89% |
| Q3 2024 | 8.62% |
| Q2 2024 | -12.39% |
| Q1 2024 | -2.68% |
| Q4 2023 | 7.31% |
| Q3 2023 | -6.96% |
| Q2 2023 | -2.50% |
| Q1 2023 | 31.77% |
| Q4 2022 | -22.94% |
| Q3 2022 | 30.30% |
| Q2 2022 | 12.47% |
| Q1 2022 | -11.10% |
| Q4 2021 | 17.93% |
| Q3 2021 | 20.94% |
| Q2 2021 | 0.44% |
| Q1 2021 | -4.51% |
| Q4 2020 | 0.21% |
| Q3 2020 | 62.63% |
| Q2 2020 | 8.98% |
| Q1 2020 | -30.93% |
| Q4 2019 | 35.82% |
| Q3 2019 | -16.89% |
| Q2 2019 | 60.74% |
| Q1 2019 | -37.99% |
| Q4 2018 | 64.17% |
| Q3 2018 | -23.99% |
| Q2 2018 | 24.81% |
| Q1 2018 | -29.87% |
| Q4 2017 | 87.72% |
| Q3 2017 | -14.69% |
| Q2 2017 | 78.07% |
| Q1 2017 | 132640.00% |
| Q4 2016 | 99.76% |
| Q3 2016 | 36.26% |
| Q2 2016 | -5.52% |
| Q1 2016 | 43.96% |
| Q4 2015 | -6.94% |